Publicaciones en colaboración con investigadores/as de Hospital Severo Ochoa (14)

2024

  1. Effectiveness of Treatment Approaches in COVID-19 Pneumonia: A Comparative Evaluation between a Specialized Center and Conventional Hospitals

    Healthcare (Switzerland), Vol. 12, Núm. 14

2023

  1. COVID-19 Severity and Survival over Time in Patients with Hematologic Malignancies: A Population-Based Registry Study

    Cancers, Vol. 15, Núm. 5

2020

  1. Impact of hematologic malignancy and type of cancer therapy on COVID-19 severity and mortality: Lessons from a large population-based registry study

    Journal of Hematology and Oncology, Vol. 13, Núm. 1

  2. Three-Year Effectiveness of Dimethyl Fumarate in Multiple Sclerosis: A Prospective Multicenter Real-World Study

    CNS Drugs, Vol. 34, Núm. 12, pp. 1275-1286

  3. Tolerability and safety of dimethyl fumarate in relapsing multiple sclerosis: a prospective observational multicenter study in a real-life Spanish population

    Journal of Neurology, Vol. 267, Núm. 8, pp. 2362-2371

2018

  1. Diagnosis of invasive fungal disease in hospitalized patients with chronic obstructive pulmonary disease

    Revista Iberoamericana de Micologia, Vol. 35, Núm. 3, pp. 117-122

2016

  1. Anti-JC virus seroprevalence in a Spanish multiple sclerosis cohort JC virus seroprevalence in Spain

    Journal of the Neurological Sciences, Vol. 365, pp. 16-21

2015

  1. Comparison of the prognostic value of liver biopsy and FIB-4 index in patients coinfected with HIV and hepatitis C virus

    Clinical Infectious Diseases, Vol. 60, Núm. 6, pp. 950-958

2014

  1. Cystatin C as a predictor of mortality and cardiovascular events in a population with chronic kidney disease

    International Journal of Nephrology, Vol. 2014

  2. Effects of sustained viral response in patients with HIV and chronic hepatitis C and nonadvanced liver fibrosis

    Journal of Acquired Immune Deficiency Syndromes, Vol. 66, Núm. 3, pp. 280-287

2011

  1. Effect of accompanying antiretroviral drugs on virological response to pegylated interferon and ribavirin in patients co-infected with HIV and hepatitis C virus

    Journal of Antimicrobial Chemotherapy, Vol. 66, Núm. 12, pp. 2843-2849

2009

  1. Effect of simultaneous use of highly active antiretroviral therapy on survival of HIV patients with tuberculosis

    Journal of Acquired Immune Deficiency Syndromes, Vol. 50, Núm. 2, pp. 148-152

2008

  1. The changing pattern of tuberculosis and HIV co-infection in immigrants and Spaniards in the last 20 years

    HIV Medicine, Vol. 9, Núm. 4, pp. 227-233

2007

  1. Economic evaluation of assistance to HIV patients in a Spanish hospital

    European Journal of Internal Medicine, Vol. 18, Núm. 5, pp. 400-404